|

Obinutuzumab administration Clinical Trials

1 actively recruiting trial

Also known as: GAZYVARO® administration

Pipeline

Phase 3: 1

Top Sponsors

  • Assistance Publique - Hôpitaux de Paris1

Indications

  • Lupus Nephritis1
  • Systemic Lupus Erythematosus (SLE)1
  • Lupus1

Other1 trial

Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.